In vivo assessment of the mitochondrial response to caloric restriction in obese women by the 2-keto[1-13C ]isocaproate breath test

The 2-keto[1-C-13]isocaproate breath test has been proposed as a tool to detect mitochondrial dysfunction in alcoholic liver disease. The aim of this study was to evaluate if the 2-keto[1-C-13]isocaproate breath test could detect in vivo dynamic changes on mitochondrial activity due to caloric restriction in obese women. Fifteen obese women (body mass index [BMI] > 30 kg/m(2)) participated in the study at baseline. Ten of these women agreed to participate on a diet program to induce body weight loss. Fifteen lean women (BMI < 25 kg/m(2)) were included as a control group. The breath test was performed by the oral administration of the tracer measuring (CO2)-C-13 enrichment in breath before and after ingestion using isotope ratio mass spectrometry. Body composition, resting energy expenditure, and plasma levels of insulin and leptin were measured. There were no relationships observed between the 2-keto[1-C-13] isocaproate breath test and the plasma insulin (before diet: P = .863; after diet: P = .879), or leptin (before diet: P = .500; after diet: P = .637). In obese women before treatment, kilograms of fat free mass (P = .108), resting energy expenditure adjusted for body composition (P = .312), and the 2-keto[1-C-13]isocaproate breath test (P = .205) were similar in comparison to lean women. However, 2-keto[1-C-13]isocaproate oxidation tended to increase after dieting and was significantly higher than in controls (P = .015). These data suggest that the 2-keto[1-C-13]isocaproate breath test reflected the adaptive modifications in mitochondrial oxidation in response to caloric restriction in obese women. Copyright 2003 Elsevier, Inc. All rights reserved.